<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04824703</url>
  </required_header>
  <id_info>
    <org_study_id>Aswu/460/5/20</org_study_id>
    <nct_id>NCT04824703</nct_id>
  </id_info>
  <brief_title>Comparative Study Between Liberal and Conservative Oxygen Therapy in Mechanically Ventilated Intensive Care Patients</brief_title>
  <official_title>Comparative Study Between Liberal and Conservative Oxygen Therapy in Mechanically Ventilated Intensive Care Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aswan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aswan University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the benefits and drawbacks of high versus low oxygen therapy on mortality and&#xD;
      myocardial function in mechanically ventilated patients&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2021</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>Within 28 days from randomization</time_frame>
    <description>Death of patient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>Within 28 days from randomization</time_frame>
    <description>Elevated cardiac enzymes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute respiratory distress syndrome</measure>
    <time_frame>Within 28 days from randomization</time_frame>
    <description>Acute persistent hypoxia with bilateral lung infiltrate due to non cardiac cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sepsis</measure>
    <time_frame>Within 28 days from randomization</time_frame>
    <description>Systolic blood pressure &lt; 90 Respiratory rate &gt; 22 Heart rate &gt; 100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>Within 28 days from randomization</time_frame>
    <description>Cerebrovascular accidents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical Ventilator free days</measure>
    <time_frame>Within 28 days from randomization</time_frame>
    <description>Days without mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shock</measure>
    <time_frame>Within 28 days from randomization</time_frame>
    <description>Systolic blood pressure &lt; 90 mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgery revision</measure>
    <time_frame>Within 28 days from randomization</time_frame>
    <description>Surgical re exploration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vasopressor</measure>
    <time_frame>Within 28 days from randomization</time_frame>
    <description>Use of vasopressors as norepinephrine and epinephrine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU stay</measure>
    <time_frame>Within 28 days from randomization</time_frame>
    <description>Duration of intensive care stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>Within 28 days from randomization</time_frame>
    <description>Duration of hospital stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Oxygen Therapy</condition>
  <arm_group>
    <arm_group_label>Conservative oxygen therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spo2 alarm limit will be set as follow: - upper limit 94% and lower limit 88%&#xD;
If spo2 &gt;94% Unless fio2 is 0.21%, decrease fio2 by 0.10% at intervals no longer than 5 minutes till spo2 = 94%&#xD;
If spo2 within target Decrease fio2 0.05% at intervals no longer than 30 min till fio2 0.21% reached or spo2 = 88 %&#xD;
If spo2 &lt; 88 % return to previous spo2 that achieve target spo2.&#xD;
if an arterial blood gas demonstrate that the PaO2 is &lt; 60 mmHg FiO2 will increased if clinically appropriate irrespective of the SpO2 reading ( target po2 60-100 mmhg )&#xD;
During intubation, airway suction, tracheostomy, bronchoscopy, transportation outside of the ICU for radiological or other investigations or for procedures or operations, other critical situations such as hemodynamic collapse, patients will receive standard (non-study)treatment.&#xD;
Echocardiography on randomization and at end of the study: we will calculate stroke volume according to Simpson's apical four view</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liberal oxygen therapy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Spo2 target &gt; 95%&#xD;
No specific measures will be taken to avoid high fio2 or high po2&#xD;
Use of upper alarm limit for spo2 will be prohibited&#xD;
Echocardiography on randomization and at end of the study: we will calculate stroke volume according to Simpson's apical four view</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxygen</intervention_name>
    <description>Decreasing fraction of inspired oxygen and its effect on mortality and myocardial function&#xD;
administered by invasive mechanical ventilation with fraction of inspired oxygen between 0.21 and 1</description>
    <arm_group_label>Conservative oxygen therapy</arm_group_label>
    <arm_group_label>Liberal oxygen therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adults aged 18 years or older admitted to ICU and expected to receive mechanical&#xD;
             ventilation beyond next calendar day&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  inclusion in other trial&#xD;
&#xD;
          -  severe acute respiratory distress syndrome at time of admission&#xD;
&#xD;
          -  acute Chronic obstructive airway disease exacerbation&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  Carbon monoxide poisoning&#xD;
&#xD;
          -  Guillain Barre syndrome&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ahmed Tammam</last_name>
    <phone>201027555869</phone>
    <email>A.temooo85@gmail.com</email>
  </overall_contact>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 26, 2021</study_first_submitted>
  <study_first_submitted_qc>March 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>March 30, 2021</last_update_submitted>
  <last_update_submitted_qc>March 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aswan University Hospital</investigator_affiliation>
    <investigator_full_name>Ahmed Sayed Mohamed Tammam</investigator_full_name>
    <investigator_title>Assistant lecturer</investigator_title>
  </responsible_party>
  <keyword>Oxygen therapy and Mortality</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

